Harrow (HROW) Amortizatization of Intangibles (2015 - 2021)
Harrow (HROW) posted quarterly Amortizatization of Intangibles of $123000.0 for Q3 2021, down 41.15% year-over-year from $209000.0 in Q3 2020, and down 18.54% quarter-over-quarter from $151000.0 in Q2 2021.
Harrow (HROW) Amortizatization of Intangibles (2015 - 2021) Analysis & Trends
Harrow's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $123000.0 for Q3 2021.
- In Q3 2021, Amortizatization of Intangibles fell 41.15% year-over-year to $123000.0; the TTM figure through Sep 2021 stood at $568000.0 (down 16.72% YoY), while the FY2020 annual figure was $696000.0, up 34.36% from the prior year.
- Amortizatization of Intangibles for Q3 2021 stood at $123000.0, down from $151000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $336000.0 in Q1 2017, with the low at $123000.0 in Q3 2021.
- The 4-year median for Amortizatization of Intangibles is $148000.0 (2021), against an average of $168666.7.
- The sharpest annual moves came in 2017 and 2020: Amortizatization of Intangibles slumped 82.99% in 2017, then surged 60.77% in 2020.
- Harrow's Amortizatization of Intangibles stood at $166000.0 in 2017, then fell by 20.48% to $132000.0 in 2019, then advanced by 10.61% to $146000.0 in 2020, then decreased by 15.75% to $123000.0 in 2021.
- Business Quant data shows HROW's Amortizatization of Intangibles at $123000.0 in Q3 2021, $151000.0 in Q2 2021, and $148000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 123,000.00 |
| Sep 30, 2021 | 123,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Mar 31, 2021 | 148,000.00 |
| Mar 31, 2021 | 148,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Sep 30, 2020 | 209,000.00 |
| Sep 30, 2020 | 209,000.00 |
| Jun 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 172,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Dec 31, 2019 | 132,000.00 |
| Dec 31, 2019 | 132,000.00 |
| Sep 30, 2019 | 130,000.00 |
| Sep 30, 2019 | 130,000.00 |
| Jun 30, 2019 | 126,000.00 |
| Jun 30, 2019 | 126,000.00 |